Codexis, Inc.
CDXS•NASDAQ•Healthcare•Biotechnology

About Codexis

Codexis, Inc. provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.

Company Information

SectorHealthcare
IndustryBiotechnology
CEOAlison Moore
Founded2002
IPO DateApril 22, 2010
Employees188
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Websitewww.codexis.com
Phone650 421 8100
Address
200 Penobscot Drive Redwood City, California 94063 United States

Corporate Identifiers

CIK0001200375
CUSIP192005106
ISINUS1920051067
EIN71-0872999
SIC2860

Leadership Team & Key Executives

Dr. Alison Moore Ph.D.
President, Chief Executive Officer and Director
Georgia L. Erbez
Chief Financial Officer and Chief Business Officer
Senator Byron L. Dorgan M.B.A.
Consultant
Dr. Stefan Lutz Ph.D.
Chief Scientific Officer
Carrie McKim
Director of Investor Relations
Britton Jimenez
Senior Vice President of Sales and Marketing
Karen Frechou-Armijo
Senior Vice President and Head of Human Resources
John Schiffhauer
Senior Vice President of Intellectual Property